IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT

Exp Hematol. 2008 Feb;36(2):181-92. doi: 10.1016/j.exphem.2007.09.010. Epub 2007 Nov 26.

Abstract

Objective: Interleukin (IL)-10 is an immunosuppressive cytokine produced by many cell types, including T cells. We previously reported that a novel type of regulatory T (Treg) cells, termed HOZOT, which possesses a FOXP3+CD4+CD8+CD25+ phenotype and dual suppressor/cytotoxic activities, produced high levels of IL-10. In this study, we examined the mechanisms of high IL-10 production by HOZOT, focusing on Janus activating kinase (JAK)/signal transducers and activators of transcription (STAT) signaling pathway.

Materials and methods: We prepared five different types of T cells, including HOZOT from human umbilical cord blood. Cytokine productions of IL-10, interferon-gamma (IFN-gamma), and tumor necrosis factor-alpha (TNF-alpha) were compared among these T cells after anti-CD3/CD28 antibody stimulation in the presence or absence of IL-2. Specific inhibitors for JAK/STAT, nuclear factor-kappaB (NF-kappaB), and nuclear factor for activated T cell (NFAT) were used to analyze signal transduction mechanisms.

Results: IL-10 production by HOZOTs was greatly enhanced by the addition of IL-2. Little or no enhancement of IFN-gamma and TNF-alpha production was observed under the same conditions. The enhancing effect of IL-2 was specific for both HOZOT and IL-10-secreting Treg cells. T helper type 2 cells, whose IL-10 production mechanisms involve GATA-3, failed to show IL-2-mediated enhancement of IL-10. Similar enhancing effects of IL-15 and IFN-alpha suggested a major role of JAK/STAT activation pathway for high IL-10 production. Further inhibitor experiments demonstrated that STAT5 rather than STAT3 was critically involved in this mechanism.

Conclusion: Our results demonstrated that IL-2 selectively enhanced production of IL-10 in HOZOT primarily through activation of STAT5, which synergistically acts with NF-kappaB/NFAT activation, implying a novel regulatory mechanism of IL-10 production in Treg cells.

MeSH terms

  • Antibodies / immunology
  • Antibodies / pharmacology
  • Antigens, CD / immunology
  • Antigens, CD / metabolism
  • Cells, Cultured
  • Humans
  • Interferon-alpha / biosynthesis
  • Interferon-alpha / immunology
  • Interferon-gamma / biosynthesis
  • Interferon-gamma / immunology
  • Interleukin-10 / biosynthesis
  • Interleukin-10 / immunology*
  • Interleukin-15 / biosynthesis
  • Interleukin-15 / immunology
  • Interleukin-2 / immunology*
  • Interleukin-2 / pharmacology
  • Janus Kinases / immunology
  • Janus Kinases / metabolism
  • Lymphocyte Activation / drug effects
  • Lymphocyte Activation / immunology*
  • NFATC Transcription Factors / immunology
  • NFATC Transcription Factors / metabolism
  • STAT3 Transcription Factor / immunology
  • STAT3 Transcription Factor / metabolism
  • STAT5 Transcription Factor / immunology*
  • STAT5 Transcription Factor / metabolism
  • Signal Transduction / drug effects
  • Signal Transduction / immunology
  • T-Lymphocytes, Cytotoxic / cytology
  • T-Lymphocytes, Cytotoxic / immunology*
  • T-Lymphocytes, Cytotoxic / metabolism
  • T-Lymphocytes, Regulatory / cytology
  • T-Lymphocytes, Regulatory / immunology*
  • T-Lymphocytes, Regulatory / metabolism
  • Tumor Necrosis Factor-alpha / biosynthesis
  • Tumor Necrosis Factor-alpha / immunology

Substances

  • Antibodies
  • Antigens, CD
  • IL10 protein, human
  • IL2 protein, human
  • Interferon-alpha
  • Interleukin-15
  • Interleukin-2
  • NFATC Transcription Factors
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • STAT5 Transcription Factor
  • Tumor Necrosis Factor-alpha
  • Interleukin-10
  • Interferon-gamma
  • Janus Kinases